Perspective Therapeutics, Inc. Common Stock — Balance Sheet (NYSE:CATX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 70.42 M64.44 M97.89 M341.1 M266.97 M Total liabilities 3.01 M3.16 M22.71 M50.43 M59.94 M Total equity 67.41 M61.28 M75.18 M290.67 M207.03 M Total liabilities & shareholders' equities 70.42 M64.44 M97.89 M341.1 M266.97 M Total debt ——1.73 M1.68 M1.63 M Net debt ——-7.51 M-225.22 M-143.07 M

News

4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

Perspective Therapeutics, Inc. (CATX) Shareholder/Analyst Call - Slideshow (NYSE:CATX) 2026-05-04

Perspective Therapeutics - Decent Prospect In Radiopharmaceuticals Field (NYSE:CATX)

Truist reiterates Buy on Perspective Therapeutics stock

RBC cuts Perspective Therapeutics stock price target on model updates

Perspective Therapeutics stock rating reiterated at Buy by BTIG

Oppenheimer reiterates Perspective Therapeutics stock rating at Outperform

Perspective Therapeutics earnings missed by $0.16, revenue fell short of estimates

Piper Sandler initiates Perspective Therapeutics stock rating at overweight

Perspective Therapeutics shares rise after $175 million offering

Perspective Therapeutics stock price target raised to $12 from $10 at H.C. Wainwright

Perspective Therapeutics, Inc. (CATX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript